Skip to main content

Table 2 Hormone receptor and HER2 receptor status by stage at presentation for investigated breast cancer categoriesa

From: Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry

 

Inflammatory breast cancer

Locally advanced breast cancer

Metastatic breast cancer

Non-T4 breast cancer

 

Stage IIIB

Stage IV

Stage IIIB

Stage IV

Stage I

Stage IIA

Stage IIB

Stage IIIA

Stage IIIB

Estrogen receptor status

         

   Estrogen receptor-negative

536 (45%)

139 (40%)

319 (33%)

573 (27%)

4,836 (15%)

4,323 (24%)

2,510 (26%)

730 (32%)

20 (36%)

   Estrogen receptor-positive

655 (55%)

207 (60%)

653 (67%)

1,533 (73%)

27,491 (85%)

13,778 (76%)

7,091 (74%)

1,565 (68%)

35 (64%)

   Number missing

329

148

296

953

6244

3,207

1,536

380

12

Progesterone receptor status

         

   Progesterone receptor-negative

640 (55%)

179 (55%)

430 (46%)

826 (42%)

8,482 (28%)

6,166 (35%)

3,495 (38%)

973 (44%)

21 (41%)

   Progesterone receptor-positive

517 (45%)

149 (45%)

511 (54%)

1,123 (58%)

22,326 (72%)

11,222 (65%)

5,748 (62%)

1,229 (56%)

30 (59%)

   Number missing

363

166

327

1,110

7,763

3,920

1,894

473

16

Hormone receptor status

         

   Hormone receptor-negative

502 (42%)

124 (36%)

303 (31%)

533 (25%)

4,426 (14%)

4,021 (22%)

2,351 (24%)

683 (30%)

18 (33%)

   Hormone receptor-positive

694 (58%)

222 (53%)

671 (69%)

1,578 (75%)

28,003 (86%)

14,138 (78%)

7,267 (76%)

1,617 (70%)

37 (67%)

   Number missing

324

148

294

948

6,142

3,149

1,519

375

12

HER2 receptor status

         

   HER2-negative

556 (60%)

147 (57%)

484 (65%)

942 (65%)

18,280 (82%)

10,110 (77%)

5,104 (72%)

1,235 (70%)

25 (64%)

   HER2-positive

367 (40%)

110 (43%)

255 (35%)

506 (35%)

4,058 (18%)

2,953 (23%)

2,010 (28%)

540 (30%)

14 (36%)

   Number missing

597

237

529

1,611

16,233

8,245

4,023

900

28

  1. aCalifornia Cancer Registry data, 1999 to 2004. HER2, human epidermal growth factor-like receptor 2.